AstraZeneca ends phase 3 cancer trial as bispecific underwhelms
8 hours ago · AstraZeneca has stopped a phase 3 trial of volrustomig in lung cancer based on interim efficacy data, narrowing the …
AstraZeneca to discontinue late-stage lung cancer trial for ... - Yahoo
17 hours ago · Aug 17 () - AstraZeneca on Monday said it is discontinuing a late stage trial that tested volrustomig plus …
AstraZeneca suffers another setback as it halts volrustomig lung cancer ...
Aug 17 (Reuters) - AstraZeneca is discontinuing a late-stage trial that tested experimental drug volrustomig plus chemotherapy in …
AstraZeneca Ends Phase 3 Lung Cancer Drug Trial After Review
8 hours ago · AstraZeneca AZN0.87%increase; up pointing triangle said it is ending the Phase 3 trial of volrustomig plus …
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After ...
8 hours ago · The trial discontinuation adds to investor scrutiny of the AstraZeneca drug pipeline following several clinical setbacks …
AstraZeneca pulls plug on late-stage lung cancer trial,...AstraZeneca ...
5 hours ago · AstraZeneca will discontinue a Phase 3 study for its investigational bispecific antibody volrustomig in non-small cell …
AstraZeneca suffers another setback as it halts volrustomig lung cancer ...
10 hours ago · Aug 17 (Reuters) - AstraZeneca said it is ending a late-stage trial that combined one of its key experimental drugs …
AstraZeneca ditches lung cancer treatment trial | The Standard
7 hours ago · The FTSE 100 firm stopped a stage volrustomig drug trial a month after halting a trial for a new heart disease …
AstraZeneca halts lung cancer trial - LinkedIn
17 hours ago · AstraZeneca has suffered a fresh setback after halting a late-stage trial for its experimental lung cancer treatment, …
AstraZeneca Halts Key Lung Cancer Trial of Volrustomig After Missed ...
17 hours ago · The decision marks a setback for the company’s dual checkpoint inhibitor strategy in lung cancer but does not raise …